Activation of the HIF pathway in cancer.

Activation of the HIF pathway in cancer.

The maintenance of oxygen homeostasis is required both in physiological development and tumour growth. Hypoxia inducible factor (HIF) plays a central role in both processes. Reliable methods for visualising HIF alpha subunits have established that HIF activation occurs in the majority of common canc...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Maxwell, P, Pugh, C, Ratcliffe, P
Formato:	Journal article
Idioma:	English
Publicado em:	2001

Registros relacionados

The HIF pathway: implications for patterns of gene expression in cancer.
por: Wykoff, C, et al.
Publicado em: (2001)

Targeting tumors through the HIF system.
por: Ratcliffe, P, et al.
Publicado em: (2000)

The pVHL-hIF-1 system. A key mediator of oxygen homeostasis.
por: Maxwell, P, et al.
Publicado em: (2001)

Hypoxia and HIF pathway in cancer and the placenta
por: Macklin, P, et al.
Publicado em: (2017)

Regulation of angiogenesis by hypoxia: role of the HIF system.
por: Pugh, C, et al.
Publicado em: (2003)

Regulation of HIF by the von Hippel-Lindau tumour suppressor: implications for cellular oxygen sensing.
por: Mole, D, et al.
Publicado em: (2001)

The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages.
por: Talks, K, et al.
Publicado em: (2000)

Regulation of the HIF pathway: enzymatic hydroxylation of a conserved prolyl residue in hypoxia-inducible factor alpha subunits governs capture by the pVHL E3 ubiquitin ligase complex.
por: Mole, D, et al.
Publicado em: (2002)

The HIF hydroxylase pathway and the tumour microenvironment
por: Ratcliffe, P
Publicado em: (2008)

The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis.
por: Pugh, C, et al.
Publicado em: (2003)

Selection of mutant CHO cells with constitutive activation of the HIF system and inactivation of the von Hippel-Lindau tumor suppressor.
por: Vaux, E, et al.
Publicado em: (2001)

Determination and comparison of specific activity of the HIF-prolyl hydroxylases.
por: Tuckerman, JR, et al.
Publicado em: (2004)

Selection and analysis of a mutant cell line defective in the hypoxia-inducible factor-1 alpha-subunit (HIF-1alpha). Characterization of hif-1alpha-dependent and -independent hypoxia-inducible gene expression.
por: Wood, S, et al.
Publicado em: (1998)

The use of dioxygen by HIF prolyl hydroxylase (PHD1).
por: McNeill, L, et al.
Publicado em: (2002)

Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma.
por: Raval, R, et al.
Publicado em: (2005)

Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
por: Kaelin, W, et al.
Publicado em: (2008)

HIF-1 and HIF-2: working alone or together in hypoxia?
por: Ratcliffe, P
Publicado em: (2007)

Cardiopulmonary function in two human disorders of the hypoxia-inducible factor (HIF) pathway: von Hippel-Lindau disease and HIF-2α gain-of-function mutation.
por: Formenti, F, et al.
Publicado em: (2011)

Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL.
por: Hon, W, et al.
Publicado em: (2002)

Genetic insights into the hypoxia-inducible factor (HIF) pathway.
por: Kiriakidis, S, et al.
Publicado em: (2007)

Oxygen sensing by HIF hydroxylases.
por: Schofield, C, et al.
Publicado em: (2004)

Signalling hypoxia by HIF hydroxylases.
por: Schofield, C, et al.
Publicado em: (2005)

Structure of factor-inhibiting hypoxia-inducible factor (HIF) reveals mechanism of oxidative modification of HIF-1 alpha.
por: Elkins, J, et al.
Publicado em: (2003)

Multiple renal cancer susceptibility polymorphisms modulate the HIF pathway.
por: Grampp, S, et al.
Publicado em: (2017)

2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
por: Mole, D, et al.
Publicado em: (2003)

ExCITED about HIF.
por: Bhattacharya, S, et al.
Publicado em: (2003)

HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligation.
por: Willam, C, et al.
Publicado em: (2006)

High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq.
por: Schödel, J, et al.
Publicado em: (2011)

Pan-cancer analysis of tissue and single-cell HIF-pathway activation using a conserved gene signature
por: Lombardi, O, et al.
Publicado em: (2022)

New horizons in hypoxia signaling pathways
por: Pugh, C, et al.
Publicado em: (2017)

Drosophila melanogaster SL2 cells contain a hypoxically inducible DNA binding complex which recognises mammalian HIF-binding sites.
por: Nagao, M, et al.
Publicado em: (1996)

Multiple renal cancer susceptibility polymorphisms modulate the HIF pathway.
por: Steffen Grampp, et al.
Publicado em: (2017-07-01)

HIF hydroxylation and cellular oxygen sensing.
por: Metzen, E, et al.
Publicado em: (2004)

Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases.
por: Schlemminger, I, et al.
Publicado em: (2003)

Regulation of HIF: prolyl hydroxylases.
por: Stolze, I, et al.
Publicado em: (2006)

Hypoxia, hypoxia-inducible factors (HIF), HIF hydroxylases and oxygen sensing.
por: Webb, J, et al.
Publicado em: (2009)

ATF5 and HIF1α cooperatively activate HIF1 signaling pathway in esophageal cancer
por: Feng He, et al.
Publicado em: (2021-05-01)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
por: Cockman, M, et al.
Publicado em: (2019)

Mutation analysis of hypoxia-inducible factors HIF1A and HIF2A in renal cell carcinoma.
por: Morris, MR, et al.
Publicado em: (2009)

Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs.
por: Wiesener, MS, et al.
Publicado em: (2003)